Chronic Rhinosinusitis Trial, Recruiting NCT02038166 Sponsor: University of Alabama at Birmingham Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Recruiting

NCT02038166
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with chronic rhinosinusitis (a long-term sinus condition) based on specific recognised medical guidelines, with symptoms lasting at least 12 weeks in a row.
  • Your sinus condition shows signs of inflammation, such as discoloured nasal discharge, nasal polyps, swelling, or redness inside the nose — confirmed by a doctor's examination or a CT scan.
  • You are 19 years of age or older and weigh at least 50 kg (about 110 lbs).
  • You are physically able to do a specific nasal test used in the study (confirm with trial site).
  • If you are a woman who could become pregnant, you must have a negative pregnancy test before joining.
  • You are willing and able to give written consent to take part.

Who may not be able to join:

  • You have had an acute (sudden) illness within the 2 weeks before the study begins.
  • You have had a major asthma attack within the 2 months before the study begins.
  • You have changed any nasal medications (such as nasal steroids or certain nasal sprays) within 14 days before the study begins.
  • You have tested positive for Hepatitis B, Hepatitis C, or HIV.
  • Your blood tests show low haemoglobin (a measure of red blood cells) or low albumin (a protein in your blood).
  • Your liver function blood tests show results that are significantly above the normal range.
  • Your kidney function blood tests show results that are significantly above the normal range.
  • You are currently pregnant or breastfeeding.
  • You have previously had an organ transplant or a bone marrow/blood cell transplant.
  • You have a history of an autoimmune disease or a granulomatous disorder (a type of inflammatory disease) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Brad Woodworth, MD, University of Alabama at Birmingham

Phone: (205) 975-6169

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2015
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measurable Difference in CFTR function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov